| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 2 | US FAERS | |
| 2 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 3 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 4 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 5 | ivacaftor | FAERS: 1 | US FAERS | |
| 6 | lumacaftor, ivacaftor drug combination | FAERS: 1 | US FAERS | |
| 7 | Mycophenolic Acid | OFFSIDES | ||
| 8 | Potassium Chloride | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.